IMPORTANT COVID INFORMATION: In an effort to ensure safety for our attendees and staff, this conference will be requiring attendees to show proof of COVID-19 vaccination at the conference. The conference will also be providing mandatory rapid COVID-19 testing upon arrival, prior to entering the event.
Learn More
  1. Home
  2. All Speakers
  3. Nigel Sheail
Nigel Sheail

Nigel Sheail

Global Head Mergers & Acquisitions and Business Development & Licensing, Novartis

Nigel Sheail is Global Head of Mergers & Acquisitions and Business Development & Licensing since September 1st, 2017 and joined Novartis in 2015 as Head of Business Development & Licensing. He is a member of the Financial Leadership Team and Executive Deal Committee.

Before joining Novartis, Nigel Sheail was Global Head of Business Development and Licensing at Bayer Healthcare AG. Prior to that Nigel Sheail was Global Head of Licensing and Head of Corporate M&A at F.Hoffmann-La Roche Ltd..

Nigel Sheail received a B.Sc (Hons. Molecular Biology) from Edinburgh University in 1987. In 1989, he became an Associate Chartered Accountant while at Ernst and Young.

My Sessions

View full schedule
View full schedule